BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21304968)

  • 21. Transglutaminase 2 transamidation activity during first-phase insulin secretion: natural substrates in INS-1E.
    Russo L; Marsella C; Nardo G; Massignan T; Alessio M; Piermarini E; La Rosa S; Finzi G; Bonetto V; Bertuzzi F; Maechler P; Massa O
    Acta Diabetol; 2013 Feb; 50(1):61-72. PubMed ID: 22382775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of natural variant transglutaminase 2 reveals molecular basis of gaining stability and higher activity.
    Ha HJ; Kwon S; Jeong EM; Kim CM; Lee KB; Kim IG; Park HH
    PLoS One; 2018; 13(10):e0204707. PubMed ID: 30321187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct transglutaminase 2-independent and transglutaminase 2-dependent pathways mediate articular chondrocyte hypertrophy.
    Johnson KA; van Etten D; Nanda N; Graham RM; Terkeltaub RA
    J Biol Chem; 2003 May; 278(21):18824-32. PubMed ID: 12606540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transglutaminase 2 Inhibitor LDN 27219 Age-Dependently Lowers Blood Pressure and Improves Endothelium-Dependent Vasodilation in Resistance Arteries.
    Pinilla E; Comerma-Steffensen S; Prat-Duran J; Rivera L; Matchkov VV; Buus NH; Simonsen U
    Hypertension; 2021 Jan; 77(1):216-227. PubMed ID: 33249864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transglutaminase 2 undergoes a large conformational change upon activation.
    Pinkas DM; Strop P; Brunger AT; Khosla C
    PLoS Biol; 2007 Dec; 5(12):e327. PubMed ID: 18092889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification.
    Johnson KA; Terkeltaub RA
    J Biol Chem; 2005 Apr; 280(15):15004-12. PubMed ID: 15691824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional significance of five noncanonical Ca2+-binding sites of human transglutaminase 2 characterized by site-directed mutagenesis.
    Király R; Csosz E; Kurtán T; Antus S; Szigeti K; Simon-Vecsei Z; Korponay-Szabó IR; Keresztessy Z; Fésüs L
    FEBS J; 2009 Dec; 276(23):7083-96. PubMed ID: 19878304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transglutaminase 2 protects against ischemic stroke.
    Filiano AJ; Tucholski J; Dolan PJ; Colak G; Johnson GV
    Neurobiol Dis; 2010 Sep; 39(3):334-43. PubMed ID: 20451610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isopeptidase activity of human transglutaminase 2: disconnection from transamidation and characterization by kinetic parameters.
    Király R; Thangaraju K; Nagy Z; Collighan R; Nemes Z; Griffin M; Fésüs L
    Amino Acids; 2016 Jan; 48(1):31-40. PubMed ID: 26250429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity.
    Begg GE; Holman SR; Stokes PH; Matthews JM; Graham RM; Iismaa SE
    J Biol Chem; 2006 May; 281(18):12603-9. PubMed ID: 16522628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition or ablation of transglutaminase 2 impairs astrocyte migration.
    Monteagudo A; Ji C; Akbar A; Keillor JW; Johnson GVW
    Biochem Biophys Res Commun; 2017 Jan; 482(4):942-947. PubMed ID: 27899316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications.
    Grosso H; Mouradian MM
    Pharmacol Ther; 2012 Mar; 133(3):392-410. PubMed ID: 22212614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Tissue Transglutaminase Catalytic and Guanosine Triphosphate-Binding Domains in Renal Cell Carcinoma Progression.
    Ulukan B; Bihorac A; Sipahioglu T; Kiraly R; Fesus L; Telci D
    ACS Omega; 2020 Nov; 5(43):28273-28284. PubMed ID: 33163811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transglutaminase type 2-dependent selective recruitment of proteins into exosomes under stressful cellular conditions.
    Diaz-Hidalgo L; Altuntas S; Rossin F; D'Eletto M; Marsella C; Farrace MG; Falasca L; Antonioli M; Fimia GM; Piacentini M
    Biochim Biophys Acta; 2016 Aug; 1863(8):2084-92. PubMed ID: 27169926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of transglutaminase 2 in A
    Vyas FS; Nelson CP; Dickenson JM
    Eur J Pharmacol; 2018 Jan; 819():144-160. PubMed ID: 29208472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses.
    Stephens P; Grenard P; Aeschlimann P; Langley M; Blain E; Errington R; Kipling D; Thomas D; Aeschlimann D
    J Cell Sci; 2004 Jul; 117(Pt 15):3389-403. PubMed ID: 15199098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competitive Binding of Magnesium to Calcium Binding Sites Reciprocally Regulates Transamidase and GTP Hydrolysis Activity of Transglutaminase 2.
    Jeong EM; Lee KB; Kim GE; Kim CM; Lee JH; Kim HJ; Shin JW; Kwon MA; Park HH; Kim IG
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type 2 transglutaminase differentially modulates striatal cell death in the presence of wild type or mutant huntingtin.
    Ruan Q; Quintanilla RA; Johnson GV
    J Neurochem; 2007 Jul; 102(1):25-36. PubMed ID: 17403029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of protein modifications mediated by transglutaminase 2 in human viral diseases.
    Jeon JH; Kim IG
    Front Biosci; 2006 Jan; 11():221-31. PubMed ID: 16146727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opposing effects of two tissue transglutaminase protein isoforms in neuroblastoma cell differentiation.
    Tee AEL; Marshall GM; Liu PY; Xu N; Haber M; Norris MD; Iismaa SE; Liu T
    J Biol Chem; 2010 Feb; 285(6):3561-3567. PubMed ID: 20007697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.